The global Infant Clinical Nutrition Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Oral, Enteral, Intravenous), By Application (Hospital, Nursery Garden, Others)
In 2024, the infant clinical nutrition market is expanding, driven by the increasing prevalence of preterm births and neonatal health issues. Clinical nutrition products, designed to meet the specific needs of vulnerable infants, are gaining importance in neonatal care. The market is benefiting from advancements in nutritional science and formulations that enhance the efficacy and safety of clinical nutrition products. Partnerships between healthcare providers and manufacturers are also fostering the development and adoption of innovative clinical nutrition solutions.
The market report analyses the leading companies in the industry including Abbott Laboratories, B. Braun Melsungen, Baxter International, Claris Lifesciences, Danone S.A., Fresenius Kabi, Mead Johnson Nutrition, Meiji Holdings Co., Ltd., Nestle Health Science, Nutricia North America, and Others.
The most prominent trend in the Infant Clinical Nutrition Market is the rising demand for specialized clinical nutrition products. As the prevalence of medical conditions and nutritional deficiencies in infants increases, there is a growing need for clinical nutrition solutions that address specific health issues such as prematurity, allergies, and metabolic disorders. This trend is driven by advancements in medical science and the recognition of the importance of tailored nutrition in supporting the health and development of vulnerable infants. The demand for specialized clinical nutrition products is encouraging manufacturers to innovate and develop targeted solutions that cater to the unique needs of infants with medical conditions.
A key driver for the Infant Clinical Nutrition Market is the increase in preterm births and the growing emphasis on neonatal care. Preterm infants often require specialized nutrition to support their growth and development due to their underdeveloped digestive systems and higher nutritional needs. The rising incidence of preterm births is driving the demand for clinical nutrition products that provide essential nutrients in an easily digestible form. The focus on improving neonatal care and outcomes is significantly driving the market as healthcare providers seek effective nutritional solutions for preterm and critically ill infants.
One potential opportunity in the Infant Clinical Nutrition Market lies in the expansion into emerging markets with improved healthcare infrastructure. As healthcare systems in regions such as Asia-Pacific, Latin America, and Africa continue to develop, there is a growing awareness and demand for specialized infant clinical nutrition products. By focusing on these emerging markets, manufacturers can tap into a large and underserved population of infants in need of clinical nutrition solutions. This focus on geographic expansion can drive market growth and improve access to high-quality clinical nutrition products for infants in developing regions.
Among the types in the Infant Clinical Nutrition Market, the Oral type is the largest segment. Oral infant clinical nutrition refers to nutritional supplements or formulas that are administered orally, either in liquid or powder form. These products are widely used in clinical settings and at home to meet the nutritional needs of infants who cannot consume adequate nutrition through regular feeding alone. Oral nutrition solutions are preferred for their ease of administration, ability to deliver specific nutrients tailored to individual requirements, and their role in supporting growth and development during infancy. They are prescribed by healthcare professionals based on the infant's medical condition, nutritional deficiencies, or feeding challenges, making them integral to pediatric healthcare protocols.
The Hospital application segment is projected to be the fastest-growing in the Infant Clinical Nutrition Market through 2032. This growth is driven by increasing admissions of infants to hospitals for specialized medical care, where clinical nutrition plays a crucial role in supporting recovery and optimal growth. Hospitals utilize infant clinical nutrition products extensively to address nutritional deficiencies, support premature infants, manage gastrointestinal disorders, and facilitate post-surgical recovery. The demand for high-quality, specialized nutrition solutions in hospital settings is rising due to advancements in medical technology, improved diagnosis of nutritional needs, and enhanced awareness among healthcare providers about the importance of early nutritional intervention in infant health outcomes. As hospitals continue to prioritize comprehensive infant care, the adoption of advanced oral and enteral nutrition solutions is expected to drive significant growth in the market.
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
B. Braun Melsungen
Baxter International
Claris Lifesciences
Danone S.A.
Fresenius Kabi
Mead Johnson Nutrition
Meiji Holdings Co., Ltd.
Nestle Health Science
Nutricia North America
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Infant Clinical Nutrition Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Infant Clinical Nutrition Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Infant Clinical Nutrition Market Share by Company, 2023
4.1.2. Product Offerings of Leading Infant Clinical Nutrition Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Infant Clinical Nutrition Market Drivers
6.2. Infant Clinical Nutrition Market Challenges
6.6. Infant Clinical Nutrition Market Opportunities
6.4. Infant Clinical Nutrition Market Trends
Chapter 7. Global Infant Clinical Nutrition Market Outlook Trends
7.1. Global Infant Clinical Nutrition Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Infant Clinical Nutrition Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Infant Clinical Nutrition Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 8. Global Infant Clinical Nutrition Regional Analysis and Outlook
8.1. Global Infant Clinical Nutrition Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Infant Clinical Nutrition Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Infant Clinical Nutrition Regional Analysis and Outlook
8.2.2. Canada Infant Clinical Nutrition Regional Analysis and Outlook
8.2.3. Mexico Infant Clinical Nutrition Regional Analysis and Outlook
8.3. Europe Infant Clinical Nutrition Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Infant Clinical Nutrition Regional Analysis and Outlook
8.3.2. France Infant Clinical Nutrition Regional Analysis and Outlook
8.3.3. United Kingdom Infant Clinical Nutrition Regional Analysis and Outlook
8.3.4. Spain Infant Clinical Nutrition Regional Analysis and Outlook
8.3.5. Italy Infant Clinical Nutrition Regional Analysis and Outlook
8.3.6. Russia Infant Clinical Nutrition Regional Analysis and Outlook
8.3.7. Rest of Europe Infant Clinical Nutrition Regional Analysis and Outlook
8.4. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) by Country (2021-2032)
8.4.1. China Infant Clinical Nutrition Regional Analysis and Outlook
8.4.2. Japan Infant Clinical Nutrition Regional Analysis and Outlook
8.4.3. India Infant Clinical Nutrition Regional Analysis and Outlook
8.4.4. South Korea Infant Clinical Nutrition Regional Analysis and Outlook
8.4.5. Australia Infant Clinical Nutrition Regional Analysis and Outlook
8.4.6. South East Asia Infant Clinical Nutrition Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Infant Clinical Nutrition Regional Analysis and Outlook
8.5. South America Infant Clinical Nutrition Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Infant Clinical Nutrition Regional Analysis and Outlook
8.5.2. Argentina Infant Clinical Nutrition Regional Analysis and Outlook
8.5.3. Rest of South America Infant Clinical Nutrition Regional Analysis and Outlook
8.6. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Infant Clinical Nutrition Regional Analysis and Outlook
8.6.2. Africa Infant Clinical Nutrition Regional Analysis and Outlook
Chapter 9. North America Infant Clinical Nutrition Analysis and Outlook
9.1. North America Infant Clinical Nutrition Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Infant Clinical Nutrition Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Infant Clinical Nutrition Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Infant Clinical Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 10. Europe Infant Clinical Nutrition Analysis and Outlook
10.1. Europe Infant Clinical Nutrition Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Infant Clinical Nutrition Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Infant Clinical Nutrition Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Infant Clinical Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 11. Asia Pacific Infant Clinical Nutrition Analysis and Outlook
11.1. Asia Pacific Infant Clinical Nutrition Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 12. South America Infant Clinical Nutrition Analysis and Outlook
12.1. South America Infant Clinical Nutrition Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Infant Clinical Nutrition Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Infant Clinical Nutrition Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Infant Clinical Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 13. Middle East and Africa Infant Clinical Nutrition Analysis and Outlook
13.1. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) by Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Chapter 14. Infant Clinical Nutrition Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Abbott Laboratories
B. Braun Melsungen
Baxter International
Claris Lifesciences
Danone S.A.
Fresenius Kabi
Mead Johnson Nutrition
Meiji Holdings Co., Ltd.
Nestle Health Science
Nutricia North America
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Infant Clinical Nutrition Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Infant Clinical Nutrition Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Infant Clinical Nutrition Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Infant Clinical Nutrition Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Infant Clinical Nutrition Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Infant Clinical Nutrition Market Share (%) By Regions (2021-2032)
Table 12 North America Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Table 15 South America Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Table 17 North America Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Table 18 North America Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Table 19 North America Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Table 26 South America Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Table 27 South America Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Table 28 South America Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Infant Clinical Nutrition Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Infant Clinical Nutrition Market Share (%) By Regions (2023)
Figure 6. North America Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 12. France Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 12. China Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 14. India Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Infant Clinical Nutrition Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Infant Clinical Nutrition Revenue (USD Million) By Product (2021-2032)
By Type
Oral
Enteral
Intravenous
By Application
Hospital
Nursery Garden
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Infant Clinical Nutrition Market Size is valued at $4.8 Billion in 2024 and is forecast to register a growth rate (CAGR) of 5.7% to reach $7.5 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, B. Braun Melsungen, Baxter International, Claris Lifesciences, Danone S.A., Fresenius Kabi, Mead Johnson Nutrition, Meiji Holdings Co., Ltd., Nestle Health Science, Nutricia North America
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume